Suomi - suomi - Fimea (Suomen lääkevirasto)

paranova oy - indapamide, perindopril arginine - tabletti, kalvopäällysteinen - 10 mg / 2,5 mg - perindopriili ja diureetit

Suomi - suomi - Fimea (Suomen lääkevirasto)

paranova oy - perindoprilum argininum - tabletti, kalvopäällysteinen - 10 mg - perindopriili

Suomi - suomi - Fimea (Suomen lääkevirasto)

orifarm oy - perindoprilum argininum - tabletti, kalvopäällysteinen - 10 mg - perindopriili

Suomi - suomi - Fimea (Suomen lääkevirasto)

sandoz a/s sandoz a/s - ethinylestradiolum,etonogestrelum - depotlääkevalmiste, emättimeen - 0.120 mg / 0.015 mg / 24 h - progestogeeniä ja estrogeeniä sisältävät emätinrenkaat

Suomi - suomi - Fimea (Suomen lääkevirasto)

ceva-phylaxia co. ltd. - ibd elävä heikennetty virus, serotyyppi 1, kanta syza26 - injektiokonsentraatti ja liuotin, suspensiota varten - gumboron tauti -rokote

Suomi - suomi - Fimea (Suomen lääkevirasto)

ceva-phylaxia veterinary biologicals co. ltd. - marek's disease virus, serotype 1, cvi-988 - injektiokonsentraatti ja liuotin, suspensiota varten - marekin tauti -rokote

Euroopan unioni - suomi - EMA (European Medicines Agency)

ceva-phylaxia veterinary biologicals co. ltd - turkey herpes virus, strain rhvt/nd/ibd, expressing the fusion protein of newcastle disease virus and the vp2 protein of infectious bursal disease virus, live recombinant - immunologiset lääkkeet - embryonated chicken eggs; chicken - for the active immunisation of one-day-old chicks or 18-day-old chicken embryonated eggs to reduce mortality, clinical signs and lesions caused by newcastle disease virus (ndv) and to reduce virus shedding; to reduce mortality, clinical signs and bursa lesions caused by very virulent infectious bursal disease virus (ibdv); to reduce mortality, clinical signs and lesions caused by classical marek’s disease virus (mdv).

Euroopan unioni - suomi - EMA (European Medicines Agency)

ceva-phylaxia co. ltd. - live recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus (rfp-lt) and avian encephalomyelitis virus, strain calnek 1143 (ae) - immunologicals for aves, live viral vaccines, domestic fowl - kana - for active immunisation of chickens of 8 to 13 weeks of age in order to reduce the skin lesions due to fowlpox, to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis and to prevent egg production losses due to avian encephalomyelitis.

Euroopan unioni - suomi - EMA (European Medicines Agency)

ceva-phylaxia co. ltd. - recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus, live - kana - for active immunisation of chickens from 8 weeks of age in order to reduce the skin lesions due to fowlpox and to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis.

Euroopan unioni - suomi - EMA (European Medicines Agency)

amryt pharmaceuticals dac - dry extract from birch bark (der 5-10 : 1), extraction solvent n-heptane 95% (w/w) - epidermolysis bullosa dystrophica; epidermolysis bullosa, junctional - valmisteet haavojen ja haavaumien hoitoon - treatment of partial thickness wounds associated with dystrophic and junctional epidermolysis bullosa (eb) in patients 6 months and older.